Bio-Medical Applications Of Mississippi, Inc. Chain: Fresenius Medical Care Location: 30 Ponderosa Avenue, De Kalb, Mississippi, 39328 Rating: Phone: (601) 743-4565 |
News Archive
Immune cells that normally repair tissues in the body can be fooled by tumors when cancer starts forming in the lungs and instead help the tumor become invasive, according to a surprising discovery reported by Mount Sinai scientists in Nature in June.
Researchers have identified a patient with a unique variant of HIV that is resistant to multiple classes of antiretroviral drugs and associated with the rapid development of AIDS, reporting their findings in this week's issue of The Lancet.
Bellicum Pharmaceuticals, Inc. today announced the presentation of Phase I/II safety and efficacy data for BPX-101, a novel drug-activated dendritic cell vaccine for metastatic castrate resistant prostate cancer (mCRPC), in three separate posters at the 2011 Genitourinary Cancers Symposium held in Orlando, Florida on February 17 – 19, 2011.
Following the conclusion of a series of meetings with the United States Food and Drug Administration (FDA), GTx, Inc. announced today the clinical trial design for the two Phase III Ostarine registration studies for the prevention and treatment of muscle wasting in patients with non-small cell lung cancer (NSCLC).
When proteins change their structure and clump together, formation of amyloid fibrils and plaques may occur. Such 'misfolding' and 'protein aggregation' processes damage cells and cause diseases such as Alzheimer's and type 2 diabetes. A team of scientists from the Technical University of Munich headed by Professor Aphrodite Kapurniotu have now developed molecules that suppress protein aggregation and could pave the way for new treatments to combat Alzheimer's, type 2 diabetes and other cell-degenerative diseases.
› Verified 9 days ago
Dialysis is used as a temporary measure in either acute kidney injury or in those awaiting kidney transplant and as a permanent measure in those for whom a transplant is not indicated or not possible. Dialysis facility in medicare covers outpatient maintenance dialysis treatments, training for self-dialysis, self-dialysis support services and self-dialysis equipment and supplies. In some cases, Medicare may cover ambulance transportation when the patient has End-Stage Renal Disease (ESRD), need dialysis, and need ambulance transportation to or from a dialysis facility.
The star rating shows how well a dialysis center delivers care compared to the national average, based on Medicare data. Each dialysis center receives a rating between 1 and 5 stars, with 3 stars representing the national average. A five-star rating means a center has quality of care that is considered 'much above average' compared to other dialysis facilities. A one or two-star rating means that measured health outcomes for that center were below average. The star rating is part of Medicare's work to make data on the quality of patient care easier to understand and use. Patient survey results aren't included in the star rating.